155 related articles for article (PubMed ID: 37113556)
1. CSRP1 Promotes Colon Adenocarcinoma Growth and Serves as an Independent Risk Biomarker for Worse Prognosis.
Yu S; Zhao H; Meng H; Shi S; Cao S; Bian T; Ruan C
Genet Res (Camb); 2023; 2023():8586507. PubMed ID: 37113556
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of high YY1AP1 and PCNA expression in colon adenocarcinoma.
Ho YJ; Lin YM; Huang YC; Shi B; Yeh KT; Gong Z; Lu JW
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):173-180. PubMed ID: 29037809
[TBL] [Abstract][Full Text] [Related]
3. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
Miao Z; Liu S; Xiao X; Li D
Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
[TBL] [Abstract][Full Text] [Related]
4. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
[TBL] [Abstract][Full Text] [Related]
5. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
Huang W; Liu Z; Li Y; Liu L; Mai G
J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
[TBL] [Abstract][Full Text] [Related]
6. High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma.
Yang Y; Ye F; Xia T; Wang Q; Zhang Y; Du J
BMC Cancer; 2022 May; 22(1):487. PubMed ID: 35501725
[TBL] [Abstract][Full Text] [Related]
7. MCM5 is an oncogene of colon adenocarcinoma and promotes progression through cell cycle control.
Mao J; Shen J; Lu X; Cai Y; Tao R; Deng Y; Zhang Y; Wu Y; Chen W
Acta Histochem; 2023 Aug; 125(6):152072. PubMed ID: 37385108
[TBL] [Abstract][Full Text] [Related]
8. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
Front Immunol; 2022; 13():881359. PubMed ID: 35911752
[TBL] [Abstract][Full Text] [Related]
9. AEBP1, a prognostic indicator, promotes colon adenocarcinoma cell growth and metastasis through the NF-κB pathway.
Xing Y; Zhang Z; Chi F; Zhou Y; Ren S; Zhao Z; Zhu Y; Piao D
Mol Carcinog; 2019 Oct; 58(10):1795-1808. PubMed ID: 31219650
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of WNK lysine deficient protein kinase 1 is associated with poor prognosis of colon adenocarcinoma.
Jiang H; Cheng X; Liang Y; Wang Y; Li Y; Li Y
Ir J Med Sci; 2023 Feb; 192(1):57-64. PubMed ID: 35138567
[TBL] [Abstract][Full Text] [Related]
12. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
Jin L; Li C; Liu T; Wang L
Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
[TBL] [Abstract][Full Text] [Related]
13. [High expression of ANKRD6 is an indicator for poor prognosis of colon adenocarcinoma].
Zhao H; Liu G; Li Y; Yang N; Zhao J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Oct; 43(10):1715-1724. PubMed ID: 37933647
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
15. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinase BRCC3 promotes the migration, invasion and EMT progression of colon adenocarcinoma by stabilizing MET expression.
Feng X; He S; Chen Y; Zhang L
Genes Genomics; 2024 May; 46(5):637-646. PubMed ID: 38470543
[TBL] [Abstract][Full Text] [Related]
17. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma.
Yu M; Yu HL; Li QH; Zhang L; Chen YX
J Biochem Mol Toxicol; 2019 Dec; 33(12):e22411. PubMed ID: 31621980
[TBL] [Abstract][Full Text] [Related]
18. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
19. Elevated expression of CXCL3 in colon cancer promotes malignant behaviors of tumor cells in an ERK-dependent manner.
Cheng Y; Yang X; Liang L; Xin H; Dong X; Li W; Li J; Guo X; Li Y; He J; Zhang C; Wang W
BMC Cancer; 2023 Nov; 23(1):1162. PubMed ID: 38031087
[TBL] [Abstract][Full Text] [Related]
20. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
